Strengthening the scale-up and uptake of effective interventions for sex workers for population impact in Zimbabwe.
Africa
HIV infection
HIV prevention
HIV testing
Zimbabwe
sex workers
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
09
11
2018
accepted:
13
05
2019
entrez:
23
7
2019
pubmed:
23
7
2019
medline:
10
7
2020
Statut:
ppublish
Résumé
UNAIDS' goal of ending AIDS by 2030 is unreachable without better targeting of testing, prevention and care. Female sex workers (FSW) in Zimbabwe are at high risk of HIV acquisition and transmission. Here, we report on collated programme and research data from Zimbabwe's national sex work programme. We also assess the potential for wider population impact of FSW programmes by modelling the impact on HIV incidence of eliminating transmission through FSW (i.e. calculate the population attributable fraction of incidence attributable to sex work). Descriptive analyses of individual-level programme data collected from FSW between 2009 and June 2018 are triangulated with data collected through 37 respondent driven sampling surveys from 19 sites in Zimbabwe 2011 to 2017. We describe programme coverage, uptake, retention and patterns of sex work behaviour and gaps in service provision. An individual-level stochastic simulation model is used to reconstruct the epidemic and then the incidence compared with the counter-factual trend in incidence from 2010 had transmission through sex work been eliminated from that date. Sisters has reached >67,000 FSW since 2009, increasing attendance as number of sites, programme staff and peer educators were increased. Over 57% of all FSW estimated to be working in Zimbabwe in 2017 (n = 40,000) attended the programme at least once. The proportion of young FSW reached has increased with introduction of the "Young Sisters programme." There are no clear differences in pattern of sex work across settings. Almost all women report condom use with clients at last sex (95%); however, consistent condom use with clients in the last month varies from 52% to 95% by site. Knowledge of HIV-positive status has increased from 48 to 78% between 2011 and 2016, as has prevalence of ART use among diagnosed women (29 to 67%). Although subject to uncertainty, modelling suggests that 70% (90% range: 32%, 93%) of all new infections in Zimbabwe from 2010 are directly or indirectly attributable to transmission via sex work. It is feasible to increase coverage and impact of sex work programming through community-led scale-up of evidence-based interventions. Eliminating transmission through commercial sex would likely have a substantial impact on new infections occurring more widely across Zimbabwe.
Identifiants
pubmed: 31328445
doi: 10.1002/jia2.25320
pmc: PMC6643097
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25320Subventions
Organisme : UN Population Fund
Pays : International
Organisme : Deutsche Gesellschaft für Internationale Zusammenarbeit
Pays : International
Organisme : German Federal Ministry for Economic Cooperation and Development
Pays : International
Organisme : US Governments Key Population Challenge Fund
Pays : International
Organisme : Bill and Melinda Gates Foundation
ID : OPP1161329
Pays : International
Informations de copyright
© 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
Références
PLoS One. 2014 Sep 29;9(9):e105645
pubmed: 25265158
J Acquir Immune Defic Syndr. 2016 May 1;72(1):e1-8
pubmed: 27093516
Lancet HIV. 2018 Mar;5(3):e146-e154
pubmed: 29174084
J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25138
pubmed: 30033558
Lancet HIV. 2018 Aug;5(8):e417-e426
pubmed: 30030134
PLoS One. 2014 Sep 10;9(9):e107214
pubmed: 25207973
J Acquir Immune Defic Syndr. 2019 May 1;81(1):24-35
pubmed: 30964804
Sex Transm Infect. 2008 Oct;84 Suppl 2:ii19-23
pubmed: 18799487
AIDS. 2014 Mar 27;28(6):891-9
pubmed: 24401648
Nature. 2015 Dec 3;528(7580):S68-76
pubmed: 26633768
Global Health. 2014 Apr 03;10:22
pubmed: 24708844
J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25320
pubmed: 31328445
AIDS. 2016 Jul 31;30(12):1973-83
pubmed: 27149090
J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):375-382
pubmed: 27930599
AIDS. 2011 Mar 27;25(6):843-50
pubmed: 21192233
Lancet. 2018 Aug 25;392(10148):698-710
pubmed: 30037733
J Infect Dis. 2015 Aug 15;212(4):570-7
pubmed: 25767214
Lancet HIV. 2016 Jul;3(7):e318-22
pubmed: 27365206
J Int AIDS Soc. 2018 Nov;21(11):e25205
pubmed: 30465689
J Infect Dis. 2016 Jul 1;214(1):73-9
pubmed: 27034345
PLoS Med. 2015 Jun 16;12(6):e1001808
pubmed: 26079267
J R Stat Soc Ser A Stat Soc. 2015 Jan;178(1):241-269
pubmed: 27226702
J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S74-82
pubmed: 25723994
Lancet Glob Health. 2014 Sep;2(9):e531-e540
pubmed: 25304420
Lancet Infect Dis. 2012 Jul;12(7):538-49
pubmed: 22424777
PLoS One. 2013 Oct 15;8(10):e77080
pubmed: 24143203
Lancet. 2015 Jan 10;385(9963):172-85
pubmed: 25059938
PLoS One. 2015 Oct 21;10(10):e0121145
pubmed: 26488796
Lancet. 2018 Jul 28;392(10144):312-358
pubmed: 30032975